TrialHuman vaccines & immunotherapeutics2021

A randomized phase 1 study of the safety and immunogenicity of 2 novel pneumococcal conjugate vaccines in healthy Japanese adults in the United States.

David Fitz-Patrick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.